| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 76.79 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : 0.63 |
EPS(TTM) : 14.86 |
|
Book Value(₹) : 230.32 |
Market Cap(₹Cr) : 15,832.15 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 433.81 | 267.52 | 306.78 | 637.58 | 567.90 | 395.71 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 433.81 | 267.52 | 306.78 | 637.58 | 567.90 | 395.71 |
| Other Operating Income | 10.18 | 9.79 | 8.51 | 12.92 | 10.74 | 9.06 |
| Other Income | 26.38 | 26.97 | 25.07 | 23.59 | 22.68 | 16.75 |
| Total Income | 470.37 | 304.28 | 340.36 | 674.09 | 601.32 | 421.52 |
| Total Expenditure | 324.09 | 255.53 | 252.61 | 353.62 | 362.32 | 283.80 |
| PBIDT | 146.28 | 48.75 | 87.75 | 320.47 | 239.00 | 137.72 |
| Interest | 42.16 | 42.70 | 45.20 | 46.50 | 45.14 | 53.16 |
| PBDT | 104.12 | 6.05 | 42.55 | 273.97 | 193.86 | 84.56 |
| Depreciation | 39.98 | 38.82 | 38.66 | 39.30 | 37.60 | 43.38 |
| Tax | 10.23 | -7.63 | 0.51 | 40.91 | 27.17 | 8.51 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.61 | -16.54 | 0.29 | 44.19 | 29.10 | 2.20 |
| Reported Profit After Tax | 48.30 | -8.60 | 3.09 | 149.57 | 99.99 | 30.47 |
| Extra-ordinary Items | 0.00 | 0.00 | -13.87 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 48.30 | -8.60 | 16.96 | 149.57 | 99.99 | 30.47 |
| EPS (Unit Curr.) | 3.49 | -0.63 | 0.23 | 10.98 | 7.34 | 2.24 |
| EPS (Adj) (Unit Curr.) | 3.49 | -0.63 | 0.23 | 10.98 | 7.34 | 2.24 |
| Calculated EPS (Unit Curr.) | 3.48 | -0.62 | 0.23 | 10.98 | 7.34 | 2.24 |
| Calculated EPS (Adj) (Unit Curr.) | 3.48 | -0.62 | 0.23 | 10.98 | 7.34 | 2.24 |
| Calculated EPS (Ann.) (Unit Curr.) | 13.94 | -2.48 | 0.91 | 43.93 | 29.37 | 8.95 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 13.94 | -2.48 | 0.91 | 43.93 | 29.37 | 8.95 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.86 | 13.85 | 13.62 | 13.62 | 13.62 | 13.62 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.72 | 18.22 | 28.60 | 50.26 | 42.08 | 34.80 |
| PBDTM(%) | 24.00 | 2.26 | 13.87 | 42.97 | 34.14 | 21.37 |
| PATM(%) | 11.13 | -3.21 | 1.01 | 23.46 | 17.61 | 7.70 |
